Latest Amsurg Corp (AMSG) Headlines AmSurg Corp
Post# of 22
Posted On: 03/12/2014 5:49:58 PM
Latest Amsurg Corp (AMSG) Headlines
AmSurg Corp. to Present at the Barclays Global Healthcare Conference
Business Wire - Thu Mar 06, 9:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Barclays Global Healthcare Conference on Thursday, March 13, 2014, in Miami, Florida. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
Gentiva Posts Q4 Loss, Guides 2014 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 9:00AM CST
Gentiva Health Services, Inc. reported fourth-quarter 2013 adjusted loss of 14 cents per share
Nasdaq stocks posting largest percentage increases
AP - Wed Feb 26, 12:51PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
Q4 Earnings Beat at AmSurg, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:10AM CST
AmSurg Corp.'s fourth-quarter 2013 EPS from continuing operations climbed 22% year over year to 60 cents.
AmSurg Produces 22% Growth in Fourth-Quarter Net Earnings from Continuing Operations to $0.60 Per Diluted Share
Business Wire - Tue Feb 25, 3:00PM CST
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced financial results for the fourth quarter and year ended December 31, 2013. Revenues were $284.6 million for the quarter, an increase of 17% from $242.8 million for the fourth quarter of 2012. Net earnings from continuing operations attributable to AmSurg common shareholders increased 24% to $19.3 million for the fourth quarter of 2013 from $15.6 million for the fourth quarter of 2012 and increased 22% per diluted share to $0.60 from $0.49 per diluted share during the same periods.
SMARTRAC introduces new NTAG213 NFC tags offering features like NFC Forum N-Mark compatibility and UID mirror functionality
Business Wire - Tue Feb 25, 6:21AM CST
SMARTRAC is launching its new NTAG213 product line: BullsEye, Midas and Circus NTAG213 NFC tags come with 144 bytes user memory with password protection, are compatible with NFC Forum Type 2 Tags and ISO/IEC14443 Type A standards and offer UID mirror functionality. Moreover, BullsEye tags come with etched NFC Forum N-Mark. Sharing their memory structure and feature set, SMARTRAC's new NTAG213 products will replace the highly successful NTAG203 product range.
D-Link Announces Outdoor HD Cloud Camera Is Now Shipping
Business Wire - Thu Feb 20, 2:01AM CST
D-Link today announced that the new Outdoor HD Cloud Camera (DCS-2330L), an outdoor-ready IP surveillance solution, is now shipping. This latest addition to the D-Link(R) family of Cloud Cameras delivers advanced video monitoring features, allowing home and small business owners to keep an eye on what matters most from anywhere from a smartphone, tablet or PC with a Wi-Fi, 3G or 4G connection.
AmSurg Corp. to Present at the Citi 2014 Global Healthcare Conference
Business Wire - Tue Feb 18, 9:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Citi 2014 Global Healthcare Conference on Tuesday, February 25, 2014, in New York City. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 2:40 p.m. Eastern Time / 1:40 p.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Fourth Quarter 2013 Results
Business Wire - Tue Jan 28, 11:00AM CST
AmSurg Corp. (Nasdaq: AMSG) today announced it will release its fourth quarter and year-end 2013 financial results on Tuesday, February 25, 2014, after the market closes. The Company will also host a conference call at 9:00 a.m. Eastern Time on Wednesday, February 26, 2014. The live broadcast of AmSurg Corp.'s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations. The on-line replay will follow shortly after the call and continue for 30 days.
AmSurg Retains Neutral Rec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 5:25PM CST
On Jan 2, 2014, we reiterated our Neutral recommendation on AmSurg Corporation.
Amsurg Up 16.1% Since SmarTrend Uptrend Call (AMSG)
Comtex SmarTrend(R) - Tue Dec 17, 9:30AM CST
SmarTrend identified an Uptrend for Amsurg (NASDAQ:AMSG) on September 18th, 2013 at $39.61. In approximately 3 months, Amsurg has returned 16.12% as of today's recent price of $45.99.
21.2% Return Seen to Date on SmarTrend Amsurg Call (AMSG)
Comtex SmarTrend(R) - Mon Dec 02, 9:26AM CST
SmarTrend identified an Uptrend for Amsurg (NASDAQ:AMSG) on September 18th, 2013 at $39.61. In approximately 3 months, Amsurg has returned 21.20% as of today's recent price of $48.00.
Uptrend Call Working As Amsurg Stock Rises 19.4% (AMSG)
Comtex SmarTrend(R) - Fri Nov 22, 9:25AM CST
SmarTrend identified an Uptrend for Amsurg (NASDAQ:AMSG) on September 18th, 2013 at $39.61. In approximately 2 months, Amsurg has returned 19.38% as of today's recent price of $47.28.
AmSurg Corp. to Present at the Piper Jaffray 25th Annual Health Care Conference
Business Wire - Fri Nov 22, 9:15AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Piper Jaffray 25th Annual Health Care Conference on Tuesday, December 3, 2013, in New York City. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 1:30 p.m. Eastern Time / 12:30 p.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Amsurg Is Up 2.2% (AMSG)
Comtex SmarTrend(R) - Mon Nov 11, 11:55AM CST
When Amsurg (NASDAQ:AMSG) reported earnings two weeks ago on October 22nd, 2013, analysts, on average, expected the company to report earnings of $0.53 on sales of $264.3 million. Amsurg actually reported earnings of $0.53 per share on sales of $268.2 million, beating EPS estimates by $0.00 and beating revenue estimates by $3.9 million. Shares of Amsurg have climbed from $42.55 to $43.48, representing a gain of 2.2% since the company reported earnings 20 days ago.
Gentiva Misses on Earnings & Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 06, 1:00PM CST
Gentiva Health Services, Inc. reported third-quarter 2013 adjusted earnings of 15 cents per share, which missed the Zacks Consensus Estimate of 22 cents
DaVita Beats on Q3 Earnings, Revises Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 06, 12:40PM CST
DaVita HealthCare Partners Inc. reported third-quarter 2013 operating earnings of 98 cents per share.
AmSurg Posts In-Line Earnings, Raises EPS Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 23, 1:40PM CDT
AmSurg's third-quarter 2013 EPS from continuing operations were up 10% year over year, marking the second consecutive quarter of double-digit growth.
AmSurg Announces Third-Quarter Net Earnings from Continuing Operations of $0.53 Per Diluted Share on 19% Growth in Revenues
Business Wire - Tue Oct 22, 3:30PM CDT
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced financial results for the third quarter ended September 30, 2013. Revenues increased 19% for the quarter to $268.2 million from $224.9 million for the third quarter of 2012. Net earnings from continuing operations attributable to AmSurg common shareholders rose 12% to $17.0 million for the third quarter of 2013 compared with $15.3 million for the third quarter of 2012 and increased 10% per diluted share to $0.53 from $0.48 per diluted share.
AmSurg Corp. to Present at the Barclays Global Healthcare Conference
Business Wire - Thu Mar 06, 9:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Barclays Global Healthcare Conference on Thursday, March 13, 2014, in Miami, Florida. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
Gentiva Posts Q4 Loss, Guides 2014 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 9:00AM CST
Gentiva Health Services, Inc. reported fourth-quarter 2013 adjusted loss of 14 cents per share
Nasdaq stocks posting largest percentage increases
AP - Wed Feb 26, 12:51PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
Q4 Earnings Beat at AmSurg, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:10AM CST
AmSurg Corp.'s fourth-quarter 2013 EPS from continuing operations climbed 22% year over year to 60 cents.
AmSurg Produces 22% Growth in Fourth-Quarter Net Earnings from Continuing Operations to $0.60 Per Diluted Share
Business Wire - Tue Feb 25, 3:00PM CST
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced financial results for the fourth quarter and year ended December 31, 2013. Revenues were $284.6 million for the quarter, an increase of 17% from $242.8 million for the fourth quarter of 2012. Net earnings from continuing operations attributable to AmSurg common shareholders increased 24% to $19.3 million for the fourth quarter of 2013 from $15.6 million for the fourth quarter of 2012 and increased 22% per diluted share to $0.60 from $0.49 per diluted share during the same periods.
SMARTRAC introduces new NTAG213 NFC tags offering features like NFC Forum N-Mark compatibility and UID mirror functionality
Business Wire - Tue Feb 25, 6:21AM CST
SMARTRAC is launching its new NTAG213 product line: BullsEye, Midas and Circus NTAG213 NFC tags come with 144 bytes user memory with password protection, are compatible with NFC Forum Type 2 Tags and ISO/IEC14443 Type A standards and offer UID mirror functionality. Moreover, BullsEye tags come with etched NFC Forum N-Mark. Sharing their memory structure and feature set, SMARTRAC's new NTAG213 products will replace the highly successful NTAG203 product range.
D-Link Announces Outdoor HD Cloud Camera Is Now Shipping
Business Wire - Thu Feb 20, 2:01AM CST
D-Link today announced that the new Outdoor HD Cloud Camera (DCS-2330L), an outdoor-ready IP surveillance solution, is now shipping. This latest addition to the D-Link(R) family of Cloud Cameras delivers advanced video monitoring features, allowing home and small business owners to keep an eye on what matters most from anywhere from a smartphone, tablet or PC with a Wi-Fi, 3G or 4G connection.
AmSurg Corp. to Present at the Citi 2014 Global Healthcare Conference
Business Wire - Tue Feb 18, 9:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Citi 2014 Global Healthcare Conference on Tuesday, February 25, 2014, in New York City. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 2:40 p.m. Eastern Time / 1:40 p.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Fourth Quarter 2013 Results
Business Wire - Tue Jan 28, 11:00AM CST
AmSurg Corp. (Nasdaq: AMSG) today announced it will release its fourth quarter and year-end 2013 financial results on Tuesday, February 25, 2014, after the market closes. The Company will also host a conference call at 9:00 a.m. Eastern Time on Wednesday, February 26, 2014. The live broadcast of AmSurg Corp.'s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations. The on-line replay will follow shortly after the call and continue for 30 days.
AmSurg Retains Neutral Rec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 5:25PM CST
On Jan 2, 2014, we reiterated our Neutral recommendation on AmSurg Corporation.
Amsurg Up 16.1% Since SmarTrend Uptrend Call (AMSG)
Comtex SmarTrend(R) - Tue Dec 17, 9:30AM CST
SmarTrend identified an Uptrend for Amsurg (NASDAQ:AMSG) on September 18th, 2013 at $39.61. In approximately 3 months, Amsurg has returned 16.12% as of today's recent price of $45.99.
21.2% Return Seen to Date on SmarTrend Amsurg Call (AMSG)
Comtex SmarTrend(R) - Mon Dec 02, 9:26AM CST
SmarTrend identified an Uptrend for Amsurg (NASDAQ:AMSG) on September 18th, 2013 at $39.61. In approximately 3 months, Amsurg has returned 21.20% as of today's recent price of $48.00.
Uptrend Call Working As Amsurg Stock Rises 19.4% (AMSG)
Comtex SmarTrend(R) - Fri Nov 22, 9:25AM CST
SmarTrend identified an Uptrend for Amsurg (NASDAQ:AMSG) on September 18th, 2013 at $39.61. In approximately 2 months, Amsurg has returned 19.38% as of today's recent price of $47.28.
AmSurg Corp. to Present at the Piper Jaffray 25th Annual Health Care Conference
Business Wire - Fri Nov 22, 9:15AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Piper Jaffray 25th Annual Health Care Conference on Tuesday, December 3, 2013, in New York City. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 1:30 p.m. Eastern Time / 12:30 p.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Amsurg Is Up 2.2% (AMSG)
Comtex SmarTrend(R) - Mon Nov 11, 11:55AM CST
When Amsurg (NASDAQ:AMSG) reported earnings two weeks ago on October 22nd, 2013, analysts, on average, expected the company to report earnings of $0.53 on sales of $264.3 million. Amsurg actually reported earnings of $0.53 per share on sales of $268.2 million, beating EPS estimates by $0.00 and beating revenue estimates by $3.9 million. Shares of Amsurg have climbed from $42.55 to $43.48, representing a gain of 2.2% since the company reported earnings 20 days ago.
Gentiva Misses on Earnings & Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 06, 1:00PM CST
Gentiva Health Services, Inc. reported third-quarter 2013 adjusted earnings of 15 cents per share, which missed the Zacks Consensus Estimate of 22 cents
DaVita Beats on Q3 Earnings, Revises Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 06, 12:40PM CST
DaVita HealthCare Partners Inc. reported third-quarter 2013 operating earnings of 98 cents per share.
AmSurg Posts In-Line Earnings, Raises EPS Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 23, 1:40PM CDT
AmSurg's third-quarter 2013 EPS from continuing operations were up 10% year over year, marking the second consecutive quarter of double-digit growth.
AmSurg Announces Third-Quarter Net Earnings from Continuing Operations of $0.53 Per Diluted Share on 19% Growth in Revenues
Business Wire - Tue Oct 22, 3:30PM CDT
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced financial results for the third quarter ended September 30, 2013. Revenues increased 19% for the quarter to $268.2 million from $224.9 million for the third quarter of 2012. Net earnings from continuing operations attributable to AmSurg common shareholders rose 12% to $17.0 million for the third quarter of 2013 compared with $15.3 million for the third quarter of 2012 and increased 10% per diluted share to $0.53 from $0.48 per diluted share.
(0)
(0)Amsurg (AMSG) Stock Research Links
Scroll down for more posts ▼